Blue Turtle Bio Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- (Cancelled)
- Investors
-
2
Blue Turtle Bio General Information
Description
Developer of a bio-engineered probiotics therapeutics platform designed to treat rare genetic diseases through the gut. The company's probiotics therapeutics platform engineered gut microbe secretes an enzyme, glucocerebrosidase, enabling healthcare providers to treat Gaucher's disease.
Contact Information
Website
www.blueturtlebio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 479 Jessie Street
- Lower Nob Hill
- San Francisco, CA 94103
- United States
+1 (313) 000-0000
Blue Turtle Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 23-Aug-2016 | Cancelled | Startup | |||
| 3. Accelerator/Incubator | 23-Feb-2015 | 00000 | 00000 | Completed | Startup | |
| 2. Grant | $5K | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2012 | Completed | Startup |
Blue Turtle Bio Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Nilesh Joshi | Co-Founder |
Blue Turtle Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| IndieBio | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Wayne State's Warrior Fund | University | 000 0000 | 000000 0 |